Clinical TrialsSearch results
Number of results: 520
Other
- Post-marketing study of cilostazol: Study to Confirm Efficacy in Preventing Recurrent Cerebral Infarction in Comparison with Aspirin
- Patients with cerebral infarction (excluding cardiogenic cerebral embolism)
- Otsuka Pharmaceutical Co., Ltd.
- 2005-09-13
Recruiting
- Efficacy and safety of olanexidine gluconate for skin disinfection of blood culture collection
- Infections
- Ota Kohei
- 2022-12-05
Other
- Case-control association study to identify key single nucleotide polymorphisms (SNPs) of cardio-renal association in type 2 diabetes.
- Chronic kidney disease (CKD) due to type-2 diabetes mellitus
- Osaka University Graduate School of Medicine
- 2007-11-14
Other
- Randomized Phase II Study of Docetaxel (T) with or without Capecitabine (X) as Neoadjuvant Chemotherapy in Female Patients with Operable Breast Cancer Who were not Observed Disease Progression after 4 cycles of 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) (OOTR N003)
- Operable breast cancer
- Organization for Oncology and Translational Research (OOTR)
- 2006-02-10
Other
- Phase2/3 Study of OTS102 in Combination With Gemcitabine in Patients With Unresectable Advanced Pancreatic Cancer and Recurrent Pancreatic Cancer(PEGASUS-PC Study)
- Unresectable Advanced and Recurrent Pancreatic Cancer
- OncoTherapy Science, Inc.
- 2009-01-27
Other
- Study for the effectiveness of intensive therapy for diabetic nephropathy in unblinded, randomized intergroup comparison study.
- Diabetic Nephropathy
- Okayama University Hospital
- 2005-11-16
Other
- Open-label, randomized, controlled study peginterferon alpa-2b plus dose-escalation of ribavirin in patients with chronic hepatitis C
- Chronic hepatitis C
- Okayama University Hospital
- 2014-10-01
Other
- Open-label, randomized, controlled study evaluating dose-escalation of peginterferon alpa-2b plus ribavirin in aged patients with chronic hepatitis C
- Chronic hepatitis C
- Okayama University Hospital
- 2014-10-01
Other
- An open-label, randomized, controlled trial comparing different dosing regimens with peginterferon alpha-2a plus ribavirin in patients with chronic hepatitis C.
- Chronic hepatitis C with serogroup 1 and high viral load (>= 100 KIU/mL).
- Okayama University Hospital
- 2008-02-29
Other
- A randomized phase II study designed to compare toxicity and dose intensity between four-week versus three-week schedule of gemcitabine for advanced pancreatic cancer
- Advanced nonresectable pancreatic cancer
- Okayama University Hospital
- 2008-01-08